Furthermore, silencing of CHOP did not decrease BOLD-100-induced PARP cleavage (Supplementary Fig. S2E), suggesting that the UPR pathway plays no role in the cell death following BOLD-100 treatment in BRAFMT colorectal cancer. Here, DDIT3 is linked to colorectal cancer.